| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |